Cargando…

Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection

Recent experiments have suggested that the infectivity of simian immunodeficiency virus (SIV) and human immunodeficiency virus type-1 (HIV-1) in plasma decreases over time during primary infection. Because anti-gp41 antibodies are produced early during HIV-1 infection and form antibody-virion comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaidya, Naveen K., Ribeiro, Ruy M., Liu, Pinghuang, Haynes, Barton F., Tomaras, Georgia D., Perelson, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019451/ https://www.ncbi.nlm.nih.gov/pubmed/29973924 http://dx.doi.org/10.3389/fmicb.2018.01326

Ejemplares similares

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
por: Liao, Hua-Xin, et al.
Publicado: (2011)

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
por: Ma, Ben-Jiang, et al.
Publicado: (2011)

Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail
por: Kuwata, Takeo, et al.
Publicado: (2013)

Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
por: Dennison, S. Moses, et al.
Publicado: (2011)

Modeling the within-host dynamics of HIV infection
por: Perelson, Alan S, et al.
Publicado: (2013)

Antibody Responses during Hepatitis B Viral Infection
por: Ciupe, Stanca M., et al.
Publicado: (2014)

Identification of HIV gp41-specific antibodies that mediate killing of infected cells
por: Williams, Katherine L., et al.
Publicado: (2019)

Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
por: Caillat, Christophe, et al.
Publicado: (2021)

Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting
por: Morris, Lynn, et al.
Publicado: (2011)

Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics
por: Vaidya, Naveen K., et al.
Publicado: (2016)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
por: Huang, Jinghe, et al.
Publicado: (2012)

Neutralizing Antibodies Targeting HIV-1 gp41
por: Caillat, Christophe, et al.
Publicado: (2020)

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
por: Tomaras, Georgia D., et al.
Publicado: (2013)

The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans
por: Goyal, Ashish, et al.
Publicado: (2017)

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2022)

Accelerated Immunodeficiency by Anti-CCR5 Treatment in HIV Infection
por: Weinberger, Ariel D., et al.
Publicado: (2009)

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection
por: Ferrari, Guido, et al.
Publicado: (2017)

Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein
por: Joshi, Vinita R., et al.
Publicado: (2020)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
por: Penn-Nicholson, Adam, et al.
Publicado: (2008)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

Structural Insights into the Mechanisms of Action of Short-Peptide HIV-1 Fusion Inhibitors Targeting the Gp41 Pocket
por: Zhang, Xiujuan, et al.
Publicado: (2018)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets
por: Vaidya, Naveen K., et al.
Publicado: (2021)

Modeling the Effects of Morphine-Altered Virus Specific Antibody Responses on HIV/SIV Dynamics
por: Mutua, Jones M., et al.
Publicado: (2019)

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface
por: Huang, Jinghe, et al.
Publicado: (2014)

The Roles of Gasdermin D in Coronavirus Infection and Evasion
por: Liu, Xiang, et al.
Publicado: (2021)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
por: Sharma, SK, et al.
Publicado: (2012)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
por: Wang, Xinling, et al.
Publicado: (2021)

The immune response during acute HIV-1 infection: clues for vaccine development
por: McMichael, Andrew J., et al.
Publicado: (2009)

Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes
por: Jain, S, et al.
Publicado: (2012)

Diversification of Specificity after Maturation of the Antibody Response to the HIV gp41 Epitope ELDKWA
por: White, Henry N., et al.
Publicado: (2012)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life
por: Yates, N L, et al.
Publicado: (2013)

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
por: Frey, Gary, et al.
Publicado: (2010)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
por: Lee, Jeong Hyun, et al.
Publicado: (2015)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e55lkr54ketu7q3k7f6o2qs180